FDAnews
www.fdanews.com/articles/174247-xenios-wins-ce-mark-for-cardiac-assist-system

Xenios Wins CE Mark for Cardiac Assist System

November 25, 2015

Heilbronn, Germany-based Xenios has received CE marking for its i-cor synchronized cardiac assist system for distribution in the EU.

The device is a heartbeat-synchronized cardiac assist designed for cardiogenic shock and high-risk interventions.

It features a miniaturized pump, which assists the weakened heart with synchronized pulses that are superimposed over a patient’s weakened heartbeats, resulting in improved coronary blood flow and limited afterload compared with conventional methods.

The device is not cleared for sale in the U.S. — Michael Cipriano